Meet ContraFect — the Biotech Company Reports Developing Infectious Disease Treatments for When Antibiotics Fail

Photo by freestocks on Unsplash

Dr. Roger Pomerantz, Chairman and CEO of ContraFect Corp. CFRX, was a guest speaker at Benzinga’s Global Small Cap Conference in December 2021. 

Dr. Roger discussed the company’s biological therapies for life-threatening, drug-resistant infectious diseases. He also addresses ContraFect’s innovations at a time when many treatments for infectious diseases are of limited effectiveness.

Watch the full interview here: